CELLAVISION AB (publ) Interim report for the period January 1 - September 30, 2008
of which the third quarter accounted for SEK 20.8 million (21.1).
SEK 3.6 million (3.8).
Important events during the quarter
CellaVision in summary |
|
|
|
| ||
(MSEK) |
|
Q3 2008 |
Q3 2007 |
Jan 1- Sep 30, 2008 |
Jan 1- Sep 30, 2007 |
Full year 2007 |
Net sales |
20.8 |
21.1 |
62.1 |
55.1 |
74.6 | |
Gross profit |
16.6 |
11.4 |
42.4 |
31.2 |
45.3 | |
Operating result |
3.6 |
3.8 |
6.3 |
0.1 |
3.1 | |
Net result |
3.4 |
3.7 |
6.0 |
-0.2 |
2.6 | |
Cash flow |
-5.6 |
7.5 |
-5.0 |
-0.5 |
-0.4 |
CEO's comment
"It is exciting to report a positive result for the fifth quarter in a row - a reflection of our steady sales growth. The establishment of our own sales organisation in the US is progressing according to plan, and I am hoping to see some results from our investment before the end of the year. At the same time our partnership with Sysmex, our distributor in the US, is continuously successful.
The individual quarters are difficult to compare because we are dependent on the distributor's sales success and inventory levels. The revenue from the various geographical markets varies between the periods, which is entirely normal in this industry. Coupled with the dollar exchange rate, the positive result of the third quarter is mainly due to sales in North America. We are however expecting a more even distribution between Europe and North America for the full year."
For further information, please contact:
Yvonne Mårtensson, CEO. Phone: 0708 33 77 82, e-mail: yvonne.martensson@cellavision.se
Johan Wennerholm, CFO. Phone: 0708 33 81 68, e-mail: johan.wennerholm@cellavision.se
Download the report by pressing the link below.